Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Cheung

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 3, 2016
Consensus canadien sur la nutrition féminine : adolescence, reproduction, ménopause et au-delà, Deborah L O'Connor, Jennifer Blake, et al.
Frontiers in Immunology|January 30, 2018
Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor TypesKristina M Ilieva, Anthony Cheung, Silvia Mele, et al.
Oncoimmunology|January 30, 2018
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)Ricarda M Hoffmann, Ben G T Coumbe, Debra H Josephs, et al.
Frontiers in Immunology|April 10, 2018
Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B CellsIsabel Correa, Kristina M Ilieva, Silvia Crescioli, et al.
Cancers|April 26, 2020
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing MelanomaRicarda M Hoffmann, Silvia Crescioli, Silvia Mele, et al.
Oncotarget|June 2, 2016
Targeting folate receptor alpha for cancer treatmentAnthony Cheung, Heather J Bax, Debra H Josephs, et al.
Mabs|July 14, 2025
Tuning antibody stability and function by rational designs of framework mutationsJoseph C F Ng, Alicia Chenoweth, Maria Laura De Sciscio, et al.
Oncoimmunology|August 1, 2022
Enriched circulating and tumor-resident TGF-β<sup>+</sup> regulatory B cells in patients with melanoma promote FOXP3<sup>+</sup> TregsRobert J Harris, Zena Willsmore, Roman Laddach, et al.
Cancers|July 27, 2022
CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer ModelsAnthony Cheung, Alicia M Chenoweth, Jelmar Quist, et al.
Oncotarget|November 5, 2017
BRAF inhibitors: resistance and the promise of combination treatments for melanomaMerope Griffin, Daniele Scotto, Debra H Josephs, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 3, 2016
Consensus canadien sur la nutrition féminine : adolescence, reproduction, ménopause et au-delà, Deborah L O'Connor, Jennifer Blake, et al.
Frontiers in Immunology|January 30, 2018
Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor TypesKristina M Ilieva, Anthony Cheung, Silvia Mele, et al.
Oncoimmunology|January 30, 2018
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)Ricarda M Hoffmann, Ben G T Coumbe, Debra H Josephs, et al.
Frontiers in Immunology|April 10, 2018
Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B CellsIsabel Correa, Kristina M Ilieva, Silvia Crescioli, et al.
Cancers|April 26, 2020
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing MelanomaRicarda M Hoffmann, Silvia Crescioli, Silvia Mele, et al.
Oncotarget|June 2, 2016
Targeting folate receptor alpha for cancer treatmentAnthony Cheung, Heather J Bax, Debra H Josephs, et al.
Mabs|July 14, 2025
Tuning antibody stability and function by rational designs of framework mutationsJoseph C F Ng, Alicia Chenoweth, Maria Laura De Sciscio, et al.
Oncoimmunology|August 1, 2022
Enriched circulating and tumor-resident TGF-β<sup>+</sup> regulatory B cells in patients with melanoma promote FOXP3<sup>+</sup> TregsRobert J Harris, Zena Willsmore, Roman Laddach, et al.
Cancers|July 27, 2022
CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer ModelsAnthony Cheung, Alicia M Chenoweth, Jelmar Quist, et al.
Oncotarget|November 5, 2017
BRAF inhibitors: resistance and the promise of combination treatments for melanomaMerope Griffin, Daniele Scotto, Debra H Josephs, et al.
Pageof 5